Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study | MicrobiomeTrials← Back to trialsNCT07511049
Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-06-05Est. Completion: 2029-12-31
Enrollment target: 24 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Progressive Multifocal Leukoencephalopathy
Background:
\- Progressive multifocal leukoencephalopathy (PML) is a severe viral infection of the brain. It is caused …
Bethesda, United StatesEst. completion Jan 1, 2052
Progressive Multifocal LeukoencephalopathyMultiple SclerosisOther Neuroinflammatory Diseases With BBB Leakage
Background:
Multiple sclerosis (MS) and progressive multifocal leukoencephalopathy (PML) are disorders that affect the …
Bethesda, United StatesEst. completion Apr 1, 2030